Sentences with phrase «option for lung cancer patients»

That leaves Merck largely free of competitors in the near - term in its quest to become a go - to, first - line option for lung cancer patients in combination with chemotherapy (Merck recently surprised investors with an early FDA filing for that combination).

Not exact matches

Pembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD - L1 expression, according to the results of the phase III KEYNOTE - 024 trial presented at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred treatment option for patients with advanced non-small cell lung cancer (NSCLC) who have mutations in the EGFR gene.

«Rapid advancements in genetic testing offer new treatment options for patients with advanced lung cancer.

For Jerry «JT» Burk, a 66 - year - old architect from Houston and one of Kopetz's patients, the trial came along when his colorectal cancer had spread to his lungs and he was almost out of options.

For patients with early - stage non-small cell lung cancer (NSCLC), the only recommended treatment option is surgery.

Today, the field of immunotherapy is expanding the options for these patients — and for those with triple - negative breast cancer, recurrent Hodgkin lymphoma, melanoma, and lung cancer.